These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9484510)
41. Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep. Dzidic A; Prgomet C; Mohr A; Meyer K; Bauer J; Meyer HH; Pfaffl MW J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):163-9. PubMed ID: 16629948 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of isosteric analogues of nicotinamide adenine dinucleotide containing C-nucleotide of nicotinamide or picolinamide. Pankiewicz KW; Zeidler J; Ciszewski LA; Bell JE; Goldstein BM; Jayaram HN; Watanabe KA J Med Chem; 1993 Jun; 36(13):1855-9. PubMed ID: 8099976 [TBL] [Abstract][Full Text] [Related]
43. Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419). Watterson SH; Chen P; Zhao Y; Gu HH; Dhar TG; Xiao Z; Ballentine SK; Shen Z; Fleener CA; Rouleau KA; Obermeier M; Yang Z; McIntyre KW; Shuster DJ; Witmer M; Dambach D; Chao S; Mathur A; Chen BC; Barrish JC; Robl JA; Townsend R; Iwanowicz EJ J Med Chem; 2007 Jul; 50(15):3730-42. PubMed ID: 17585753 [TBL] [Abstract][Full Text] [Related]
44. Effect of mycophenolic acid glucuronide on inosine monophosphate dehydrogenase activity. Nowak I; Shaw LM Ther Drug Monit; 1997 Jun; 19(3):358-60. PubMed ID: 9200779 [TBL] [Abstract][Full Text] [Related]
45. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Sintchak MD; Fleming MA; Futer O; Raybuck SA; Chambers SP; Caron PR; Murcko MA; Wilson KP Cell; 1996 Jun; 85(6):921-30. PubMed ID: 8681386 [TBL] [Abstract][Full Text] [Related]
46. Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5'-monophosphate dehydrogenase. Farazi T; Leichman J; Harris T; Cahoon M; Hedstrom L J Biol Chem; 1997 Jan; 272(2):961-5. PubMed ID: 8995388 [TBL] [Abstract][Full Text] [Related]
47. The apparent inhibition of inosine monophosphate dehydrogenase by mycophenolic acid glucuronide is attributable to the presence of trace quantities of mycophenolic acid. Korecka M; Nikolic D; van Breemen RB; Shaw LM Clin Chem; 1999 Jul; 45(7):1047-50. PubMed ID: 10388481 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of mycophenolic acid glucuronidation by niflumic acid in human liver microsomes. Vietri M; Pietrabissa A; Mosca F; Pacifici GM Eur J Clin Pharmacol; 2002 May; 58(2):93-7. PubMed ID: 12012139 [TBL] [Abstract][Full Text] [Related]
49. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor. Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689 [TBL] [Abstract][Full Text] [Related]
50. Human colorectal carcinoma cells in vitro as a means to assess the metabolism of analogs of mycophenolic acid. Franklin TJ; Jacobs VN; Jones G; Ple P Drug Metab Dispos; 1997 Mar; 25(3):367-70. PubMed ID: 9172956 [TBL] [Abstract][Full Text] [Related]
51. Influence of mycophenolic acid on inosine 5'-monophosphate dehydrogenase activity in human peripheral blood mononuclear cells. Daxecker H; Raab M; Müller MM Clin Chim Acta; 2002 Apr; 318(1-2):71-7. PubMed ID: 11880114 [TBL] [Abstract][Full Text] [Related]
52. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity. Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727 [TBL] [Abstract][Full Text] [Related]
53. Use of benzofuran for concomitant protection of aldehyde and phenol groups in the preparation of mycophenolic acid analogues. Fardis M; Mertzman M; Thomas W; Kirschberg T; Collins N; Polniaszek R; Watkins WJ J Org Chem; 2006 Jun; 71(13):4835-9. PubMed ID: 16776510 [TBL] [Abstract][Full Text] [Related]
54. NAD-analogues as potential anticancer agents: conformational restrictions as basis for selectivity. Pankiewicz KW; Zatorski A; Watanabe KA Acta Biochim Pol; 1996; 43(1):183-93. PubMed ID: 8790723 [TBL] [Abstract][Full Text] [Related]
55. Recent development of IMP dehydrogenase inhibitors for the treatment of cancer. Chen L; Pankiewicz KW Curr Opin Drug Discov Devel; 2007 Jul; 10(4):403-12. PubMed ID: 17659481 [TBL] [Abstract][Full Text] [Related]
56. Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect: potential clinical implications. Weimert NA; Derotte M; Alloway RR; Woodle ES; Vinks AA Ther Drug Monit; 2007 Apr; 29(2):141-9. PubMed ID: 17417067 [TBL] [Abstract][Full Text] [Related]
57. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside. Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436 [TBL] [Abstract][Full Text] [Related]
59. Two new members of mycophenolic acid family from Penicillium brevicompactum Dierckx. Lu X; Zheng Z; Zhang H; Huo C; Dong Y; Ma Y; Ren X; Ke A; He J; Gu Y; Shi Q J Antibiot (Tokyo); 2009 Sep; 62(9):527-9. PubMed ID: 19575040 [No Abstract] [Full Text] [Related]
60. Synthesis of some monocyclic analogues of mycophenolic acid via the Johnson ortho ester Claisen rearrangement. Meza-Aviña ME; Ordoñez M; Fernández-Zertuche M; Rodríguez-Fragoso L; Reyes-Esparza J; de Los Ríos-Corsino AA Bioorg Med Chem; 2005 Dec; 13(23):6521-8. PubMed ID: 16122928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]